Abstract Disclosed are N-derivatives of thienamycin having structures I and II. <IMAGE> I +TR <IMAGE> II wherein: the bifunctional radical may contain additional unsaturation in the ring; and wherein n is an integer selected from 1-6; p is 0, 1 or 2; R1 is selected from hydrogen, alkyl having 1-6 carbon atoms, and aryl having 6-10 carbon atoms; and Z is imino (=NH), oxo (=O), hydrogen, amino, or alkyl having 1-6 carbon atoms. Such compounds and their pharmaceutically acceptable salt and ester derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
A compound having the structural formula: ##STR37## and the pharmaceutically acceptable salts thereof; wherein: R 1 is hydrogen, alkyl having from 1-6 carbon atoms or phenyl; X is imino or oxo; Y is hydrogen or alkyl having from 1-6 carbon atoms; Z is hydrogen, alkyl having from 1-6 carbon atoms or alkoxycarbonyl having from 2-7 carbon atoms; and tautomers thereof where Y or Z is hydrogen, and X is amino.
Claim 2
Dependent Claim
70 words
A compound having the structural formula: ##STR37## and the pharmaceutically acceptable salts thereof; wherein: R 1 is hydrogen, alkyl having from 1-6 carbon atoms or phenyl; X is imino or oxo; Y is hydrogen or alkyl having from 1-6 carbon atoms; Z is hydrogen, alkyl having from 1-6 carbon atoms or alkoxycarbonyl having from 2-7 carbon atoms; and tautomers thereof where Y or Z is hydrogen, and X is amino.
Claim 3
Dependent Claim
10 words
A compound according to claim 1 having the structure: ##STR38##
Claim 4
Dependent Claim
25 words
An antibiotic pharmaceutical composition comprising, in unitary dosage form, a therapeutically effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier therefor.